Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danielle Bekker Insider Profile
4 Followers
Danielle Bekker, Director at SkinBioTherapeutics, holds 43.75K shares in SkinBioTherapeutics (Ticker: GB:SBTX). Most recently, Danielle Bekker Bought 43,750p shares of SkinBioTherapeutics on Dec 16, 2022 for an estimated value of 7.00K.
Danielle Bekker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Danielle Bekker's holdings
Insider Roles
Director
Roles that Danielle Bekker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Danielle Bekker
Danielle Bekker's Trading History
List of latest transactions for each holding click on a transaction to see Danielle Bekker's performance on stock
You May Also Like
Danielle Bekker insider profile FAQ
What is the percentage of profitable transactions made by Danielle Bekker?
The percentage of profitable transactions made by Danielle Bekker is ―.
What is the average return per transaction made by Danielle Bekker?
The average return per transaction made by Danielle Bekker is ―.
What stocks does Danielle Bekker hold?
Danielle Bekker holds: GB:SBTX stocks.
What was Danielle Bekker’s latest transaction?
Danielle Bekker latest transaction was an Informative Buy of 7.00K.
What was Danielle Bekker's most profitable transaction?
Danielle Bekker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Danielle Bekker's role in SkinBioTherapeutics?
Danielle Bekker's role in SkinBioTherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.